ZAG | S&W

News

The quarterly research report of ZAG-S&W and IVC-Research Center was published

25.10.2017
The legal team at our offices in Tel Aviv, New York and Boston led an innovative and unique transaction on the Tel Aviv Stock Exchange

02.11.2017
The firm's capital market department accompanies Attunity in a public funding round on Nasdaq

13.12.2017
ZAG-S & W launches a new service, on-demand legal service on-site

08.02.2018

Transactions and IPOs

ZAG-S&W represented Therapix Biosciences in $13.8 Million Initial Public Offering

ZAG-S&W represented Therapix Biosciences in $13.8 Million Initial Public Offering

DarioHealth Corp. Prices offering of 1,450,000 Shares of Common Stock in amount of approx $4.5 million

DarioHealth Corp. Prices offering of 1,450,000 Shares of Common Stock in amount of approx $4.5 million

The firm's Capital Market department assisted Attunity in raising $20 million on the Nasdaq

The firm's Capital Market department assisted Attunity in raising $20 million on the Nasdaq

The legal team at our offices in Tel Aviv, New York and Boston led an innovative and unique transaction on the Tel Aviv Stock Exchange

The legal team at our offices in Tel Aviv, New York and Boston led an innovative and unique transaction on the Tel Aviv Stock Exchange

The International team counseled Alcobra Pharma Ltd in a unique transaction, known as a Reverse IPO.

The International team counseled Alcobra Pharma Ltd in a unique transaction, known as a Reverse IPO.

Attorney's Eran Ben- Dor & Tamir Chagal from our Tel Aviv office represented Colospan as they successfully completed a $ 7.7 million financing round and reported success with clinical trials.

Attorney's Eran Ben- Dor & Tamir Chagal from our Tel Aviv office represented Colospan as they successfully completed a $ 7.7 million financing round and reported success with clinical trials.